USCAP Thorax Revisited 2026

USCAP Thorax Revisited 2026: Course Overview

USCAP Thorax Revisited addresses lung, pleural and mediastinal pathology, with emphasis on diagnostic pitfalls, immunohistochemistry, cytology and molecular testing.

Store-listed inventory, not independently verified: 10 videos and 20 PDFs, listed size 18.72 GB. Confirm file counts, size and completeness before ordering.

Edition and Purchase Details

The store title is retained as listed. The matching official Thorax Revisited program took place October 23–24, 2025. The store-listed recording release date of January 12, 2026 has not been independently confirmed from an official release notice.

This purchase covers digital files, not live microscopy participation, publisher-platform access or faculty interaction. CME points and certificates are not included.

Accurate diagnosis of pleural disease is crucial to patient care. Pathologists are also increasingly asked to order and interpret molecular testing for lung carcinomas and other pulmonary tumors. Led by expert pathologists, this course will review common diagnostic pitfalls in thoracic pathology, cytology, and immunohistochemistry, along with new cases of mediastinal tumors, pleural tumors, and non-neoplastic lung disease. As molecular testing becomes more mainstream, interpreting these tests for lung carcinomas and other pulmonary tumors is of vital importance. Faculty will discuss issues related to molecular testing with a focus on what to order, when to order, and how to interpret the results. The original course used lectures and interactive case discussions; that format does not establish interactive access with the supplied files.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

The original program objectives address the following areas; completion of these files does not confer a credential:

• Understand when molecular testing is needed for thoracic tumors, what tests are appropriate, and how to interpret the results.
• Become familiar with morphologic features of various prevascular mediastinal lesions for establishing a reasonable differential diagnosis. Based on that differential diagnosis the participants will learn to apply reasonable small panels of ancillary tests, including immunostains and potentially cytogenetics (especially chromosome 12p alterations for germ cell tumors).
• Become familiar with morphologic features of various non neoplastic lung diseases. Cases selected will span the spectrum of cellular and fibrotic interstitial pneumonias, smoking related disease, cystic lung disease, benign lymphoid lesions (and some neoplastic mimics), vascular disease, drug reactions, the lung in systemic disease, and various granulomatous diseases. These cases form the bulk of cases sent to our large consultation practice indicating that pathologists struggle with how to report their findings and to communicate the clinical significance of what they are seeing.
• Understand the various types of pleural lesions encountered in everyday practice, their morphologic differential and mimics, and what adjunctive tests are or are not useful in working up such cases.
• Gain familiarity with the basics of thoracic cytology (lavage, EBUS, effusion) specimens, understand issues related to specimen preparation, and how and when to apply immunostains or FISH.
• Learn efficient use of immunostains for thoracic lesions and learn to recognize problems and misleading results with such stains.

Program Topics and Faculty

Topic and faculty names correspond to the official event schedule. Session titles do not establish the number of delivered files.

Primary Category: Pathology
Secondary Category: Thoracic Pathology
Meta Description: Explore USCAP Thorax Revisited topics in lung, pleural and mediastinal pathology. Check edition and file-delivery limits; no CME or certificate included.